The Spectranetics Corp (SPNC)

38.45
0.00 (0.00)
Prev Close 38.45
Open 38.45
Day Low/High 38.45 / 38.50
52 Wk Low/High 10.65 / 21.91
Volume 1.73M
Avg Volume 1.50M
Exchange
Shares Outstanding 44.05M
Market Cap 1.69B
EPS -1.40
Div & Yield N.A. (N.A)

Latest News

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.

Spectranetics Announces FDA Approval Of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval Of Stellarex™ Drug-Coated Balloon

Stellarex produces top-tier clinical outcomes with a low drug dosage

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of The Spectranetics Corporation And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of The Spectranetics Corporation And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of The...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Into Whether The Sale Of The Spectranetics Corporation To Royal Philips For $38.50 Per Share Is Fair To Shareholders

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Into Whether The Sale Of The Spectranetics Corporation To Royal Philips For $38.50 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased The Spectranetics Corporation (NASDAQ:SPNC) stock  prior to June 28, 2017 .

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of The Spectranetics Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of The Spectranetics Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of The...

SPNC Crosses Above Average Analyst Target

In recent trading, shares of Spectranetics Corp. have crossed above the average analyst 12-month target price of $31.11, changing hands for $38.35/share.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Into Whether The Sale Of The Spectranetics Corporation To Royal Philips For $38.50 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased The Spectranetics Corporation (NASDAQ:SPNC) stock  prior to June 28, 2017 .

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures point to a mixed start for Wall Street on Wednesday, June 28.

Philips Buys Medical Device Maker Spectranetics Corp.; Deal Has Enterprise Value of $2.15 Billion

Philips Buys Medical Device Maker Spectranetics Corp.; Deal Has Enterprise Value of $2.15 Billion

Royal Philips said Wednesday that it will buy medical devices maker Spectranetics Corporation in a deal that carries an enterprise value of around €1.9 billion.

Spectranetics Announces $140 Million Debt Refinancing

Strengthens Liquidity and Reduces Cost of Debt

Spectranetics Reaches Analyst Target Price

In recent trading, shares of Spectranetics Corp. have crossed above the average analyst 12-month target price of $29.00, changing hands for $29.12/share.